Description du poste
The Max Delbrück Center for Molecular Medicine in the Helmholtz Association aims to transform tomorrow’s medicine through our discoveries of today. At locations in Berlin-Buch, Berlin-Mitte, Heidelberg and Mannheim, our researchers harness interdisciplinary collaboration to decipher the complexities of disease at the systems level – from molecules and cells to organs and the entire organism. Through academic, clinical, and industry partnerships, as well as global networks, we strive to translate biological discoveries into applications that enable the early detection of deviations from health, personalize treatment, and ultimately prevent disease. First founded in 1992, the Max Delbrück Center today inspires and nurtures a diverse talent pool of 1,800 people from over 70 countries. We are 90 percent funded by the German federal government and 10 percent by the state of Berlin.
As part of the Helmholtz Association’s new research focus on Biomedical Engineering, the Max Delbrück Center is establishing a Bioengineering Innovation Center to advance research and innovation at the interface of biology, engineering, and medicine.
### **Job Description**
We are recruiting outstanding scientists with bold, cross-disciplinary research visions for Group Leader positions (equivalent to Assistant Professor level) in Berlin. The positions offer competitive start-up funding and long-term institutional support for up to nine years. We seek researchers who will push the boundaries of programmable and predictively designed therapeutics through synthetic biology, AI-guided design, and therapeutic engineering.
We particularly encourage applications in the following areas, while welcoming outstanding proposals that span these fields or establish entirely new directions in therapeutic bioengineering:
* Molecular design and engineering: Innovative approaches to designing and engineering DNA, RNA, and proteins for therapeutic applications, including engineered therapeutic modalities, synthetic regulatory elements, and programmable molecular tools.
* Cellular and immunological programming and engineering: Innovative approaches to sensing, controlling, and programming cellular states and functions for therapeutic applications, including synthetic gene circuits, cellular sensing systems, and logic gating.
* AI-driven biological engineering: Development of machine learning, generative AI, and foundation models for the predictive design of therapeutic molecules and biological systems, including approaches that integrate computational design with high-throughput experimentation and laboratory automation.
Successful candidates are expected to establish internationally competitive, independent research programs, attract external funding, and contribute to a collaborative environment that connects fundamental discoveries with therapeutic innovation.
**What we offer:**
* generous start-up funding to establish and develop your research group, including resourc